{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T10:33:52Z","timestamp":1785234832254,"version":"3.55.0"},"reference-count":95,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.mcna.2022.12.005","type":"journal-article","created":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T12:29:16Z","timestamp":1676896156000},"page":"533-554","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Alcoholic Hepatitis"],"prefix":"10.1016","volume":"107","author":[{"given":"Pranav","family":"Penninti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayooluwatomiwa D.","family":"Adekunle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwani K.","family":"Singal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.mcna.2022.12.005_bib1","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1053\/j.gastro.2016.02.042","article-title":"Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia","volume":"150","author":"Crabb","year":"2016","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.mcna.2022.12.005_bib2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","article-title":"Corticosteroid therapy of alcoholic hepatitis","volume":"75","author":"Maddrey","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mcna.2022.12.005_bib3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2147\/HMER.S197933","article-title":"Severe alcoholic hepatitis: current perspectives","volume":"11","author":"Philips","year":"2019","journal-title":"HMER"},{"issue":"5","key":"10.1016\/j.mcna.2022.12.005_bib4","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4254\/wjh.v3.i5.108","article-title":"Definition, epidemiology and magnitude of alcoholic hepatitis","volume":"3","author":"Basra","year":"2011","journal-title":"WJH"},{"issue":"2","key":"10.1016\/j.mcna.2022.12.005_bib5","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/MCG.0000000000001378","article-title":"Alcohol-associated Cirrhosis and Alcoholic Hepatitis Hospitalization Trends in the United States","volume":"55","author":"Shirazi","year":"2021","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"4","key":"10.1016\/j.mcna.2022.12.005_bib6","doi-asserted-by":"crossref","first-page":"e201997","DOI":"10.1001\/jamanetworkopen.2020.1997","article-title":"Trends in the Burden of Chronic Liver Disease Among Hospitalized US Adults","volume":"3","author":"Hirode","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"8","key":"10.1016\/j.mcna.2022.12.005_bib7","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1097\/MCG.0b013e3181fdef1d","article-title":"Clinical Characteristics and Mortality of Hospitalized Alcoholic Hepatitis Patients in the United States","volume":"45","author":"Liangpunsakul","year":"2011","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"03","key":"10.1016\/j.mcna.2022.12.005_bib8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1055\/s-2004-832936","article-title":"Epidemiology of Alcoholic Liver Disease","volume":"24","author":"Mandayam","year":"2004","journal-title":"Semin Liver Dis"},{"issue":"5","key":"10.1016\/j.mcna.2022.12.005_bib9","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s10620-017-4492-3","article-title":"Increasing Burden of Chronic Liver Disease Among Adolescents and Young Adults in the USA: A Silent Epidemic","volume":"62","author":"Doycheva","year":"2017","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.mcna.2022.12.005_bib10","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1186\/s12876-022-02430-7","article-title":"The prevalence of alcoholic and nonalcoholic fatty liver disease in adolescents and young adults in the United States: analysis of the NHANES database","volume":"22","author":"Alkhouri","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.mcna.2022.12.005_bib11","doi-asserted-by":"crossref","first-page":"k2817","DOI":"10.1136\/bmj.k2817","article-title":"Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study","volume":"362","author":"Tapper","year":"2018","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.mcna.2022.12.005_bib12","doi-asserted-by":"crossref","first-page":"e2210259","DOI":"10.1001\/jamanetworkopen.2022.10259","article-title":"Evaluation of Trends in Alcohol Use Disorder\u2013Related Mortality in the US Before and During the COVID-19 Pandemic","volume":"5","author":"Yeo","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"17","key":"10.1016\/j.mcna.2022.12.005_bib13","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1001\/jama.2022.4308","article-title":"Alcohol-Related Deaths During the COVID-19 Pandemic","volume":"327","author":"White","year":"2022","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.mcna.2022.12.005_bib14","doi-asserted-by":"crossref","first-page":"e210422","DOI":"10.1001\/jamanetworkopen.2021.0422","article-title":"Alcohol Withdrawal Rates in Hospitalized Patients During the COVID-19 Pandemic","volume":"4","author":"Sharma","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.mcna.2022.12.005_bib15","first-page":"341","article-title":"Alcohol Consumption in Response to the COVID-19 Pandemic in the United States","volume":"15","author":"Barbosa","year":"2021","journal-title":"J\u00a0Addict Med"},{"issue":"6","key":"10.1016\/j.mcna.2022.12.005_bib16","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/hep.32272","article-title":"Effect of increased alcohol consumption during COVID-19 pandemic on alcohol-associated liver disease: A modeling study","volume":"75","author":"Julien","year":"2022","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.mcna.2022.12.005_bib17","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/j.cgh.2022.03.017","article-title":"Alcohol-Associated Liver Disease Mortality Increased From 2017 to 2020 and Accelerated During the COVID-19 Pandemic","volume":"20","author":"Deutsch-Link","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.mcna.2022.12.005_bib18","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1097\/MCG.0000000000001627","article-title":"The Pandemic Within the Pandemic","volume":"56","author":"Sohal","year":"2022","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.mcna.2022.12.005_bib19","article-title":"Increasing Prevalence and Racial Disparity of Alcohol-Related Gastrointestinal and Liver Disease During the COVID-19 Pandemic: A Population-Based National Study","author":"Damjanovska","year":"2022","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"4","key":"10.1016\/j.mcna.2022.12.005_bib20","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/liv.15172","article-title":"Alcohol-related hepatitis admissions increased 50% in the first months of the COVID-19 pandemic in the USA","volume":"42","author":"Gonzalez","year":"2022","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.mcna.2022.12.005_bib21","doi-asserted-by":"crossref","first-page":"e1170","DOI":"10.1016\/j.cgh.2021.10.030","article-title":"Impact of the COVID-19 Pandemic on Hospitalizations for Alcoholic Hepatitis or Cirrhosis in Alberta, Canada","volume":"20","author":"Shaheen","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.mcna.2022.12.005_bib22","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1111\/acer.14896","article-title":"Prevalence, co-morbidities, and in-hospital mortality of patients hospitalized with alcohol-associated hepatitis in the United States from 2015 to 2019","volume":"46","author":"Marlowe","year":"2022","journal-title":"Alcohol Clin Exp Res"},{"issue":"44","key":"10.1016\/j.mcna.2022.12.005_bib23","doi-asserted-by":"crossref","first-page":"7825","DOI":"10.3748\/wjg.v19.i44.7825","article-title":"Is liver biopsy necessary in the management of alcoholic hepatitis?","volume":"19","author":"Dhanda","year":"2013","journal-title":"WJG"},{"issue":"5","key":"10.1016\/j.mcna.2022.12.005_bib24","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jhep.2021.06.019","article-title":"Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study","volume":"75","author":"Arab","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.mcna.2022.12.005_bib25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40364-015-0046-z","article-title":"Prognostic models for alcoholic hepatitis","volume":"3","author":"Rahimi","year":"2015","journal-title":"Biomark Res"},{"issue":"11","key":"10.1016\/j.mcna.2022.12.005_bib26","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1111\/j.1572-0241.2008.02104.x","article-title":"A\u00a0New Scoring System for Prognostic Stratification of Patients With Alcoholic Hepatitis","volume":"103","author":"Dominguez","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.mcna.2022.12.005_bib27","doi-asserted-by":"crossref","first-page":"301","DOI":"10.14309\/ajg.0000000000001596","article-title":"The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study","volume":"117","author":"Morales-Arr\u00e1ez","year":"2022","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.mcna.2022.12.005_bib28","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.21607","article-title":"The Lille model: A new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids","volume":"45","author":"Louvet","year":"2007","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.mcna.2022.12.005_bib29","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/gut.2010.224097","article-title":"Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data","volume":"60","author":"Mathurin","year":"2011","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.mcna.2022.12.005_bib30","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/ajg.2016.539","article-title":"A\u00a0Day-4 Lille Model Predicts Response to Corticosteroids and Mortality in Severe Alcoholic Hepatitis","volume":"112","author":"Garcia-Saenz-de-Sicilia","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.mcna.2022.12.005_bib31","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1053\/j.gastro.2015.04.044","article-title":"Combining Data From Liver Disease Scoring Systems Better Predicts Outcomes of Patients With Alcoholic Hepatitis","volume":"149","author":"Louvet","year":"2015","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.mcna.2022.12.005_bib32","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/00004836-200405000-00012","article-title":"The Role of the Discriminant Factor in the Assessment and Treatment of Alcoholic Hepatitis","volume":"38","author":"Kulkarni","year":"2004","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"3","key":"10.1016\/j.mcna.2022.12.005_bib33","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.cgh.2013.08.048","article-title":"The Breathprints in Patients with Liver Disease Identify Novel Breath Biomarkers in Alcoholic Hepatitis","volume":"12","author":"Hanouneh","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.mcna.2022.12.005_bib34","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/hep.29080","article-title":"A\u00a0prospective study of the utility of plasma biomarkers to diagnose alcoholic hepatitis","volume":"66","author":"Bissonnette","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2022.12.005_bib35","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12967-015-0623-9","article-title":"Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis","volume":"13","author":"Momen-Heravi","year":"2015","journal-title":"J\u00a0Transl Med"},{"issue":"11","key":"10.1016\/j.mcna.2022.12.005_bib36","first-page":"1857","article-title":"In Severe Alcoholic Hepatitis, Serum Keratin-18 Fragments Are Diagnostic, Prognostic, and Theragnostic Biomarkers","volume":"115","author":"Atkinson","year":"2020","journal-title":"ACG"},{"issue":"2","key":"10.1016\/j.mcna.2022.12.005_bib37","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jhep.2018.03.031","article-title":"Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis","volume":"69","author":"Brandl","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"11","key":"10.1016\/j.mcna.2022.12.005_bib38","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1038\/ajg.2014.262","article-title":"Hepatic Macrophage Activation and the LPS Pathway in Patients With Alcoholic Hepatitis: A Prospective Cohort Study","volume":"109","author":"Sandahl","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.mcna.2022.12.005_bib39","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/hep.27779","article-title":"Systemic Inflammatory Response and Serum Lipopolysaccharide Levels Predict Multiple Organ Failure and Death in Alcoholic Hepatitis","volume":"62","author":"Michelena","year":"2015","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.mcna.2022.12.005_bib40","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3390\/cells9030524","article-title":"Emerging Noninvasive Biomarkers, and Medical Management Strategies for Alcoholic Hepatitis: Present Understanding and Scope","volume":"9","author":"Gala","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.mcna.2022.12.005_bib41","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/jhep.2000.8627","article-title":"Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: A multicenter randomized trial","volume":"32","author":"Cabr\u00e9","year":"2000","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.mcna.2022.12.005_bib42","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1053\/j.gastro.2015.12.038","article-title":"Intensive Enteral Nutrition Is Ineffective for Patients With Severe Alcoholic Hepatitis Treated With Corticosteroids","volume":"150","author":"Moreno","year":"2016","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.mcna.2022.12.005_bib43","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ajg.2017.469","article-title":"ACG Clinical Guideline: Alcoholic Liver Disease","volume":"113","author":"Singal","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.mcna.2022.12.005_bib44","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.30866","article-title":"Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases","volume":"71","author":"Crabb","year":"2020","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.mcna.2022.12.005_bib45","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jhep.2018.03.018","article-title":"EASL Clinical Practice Guidelines: Management of alcohol-related liver disease","volume":"69","author":"Thursz","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"8","key":"10.1016\/j.mcna.2022.12.005_bib46","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4254\/wjh.v3.i8.205","article-title":"Corticosteroids and pentoxifylline for the treatment of alcoholic hepatitis: Current status","volume":"3","author":"Singal","year":"2011","journal-title":"World J Hepatol"},{"issue":"17","key":"10.1016\/j.mcna.2022.12.005_bib47","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMoa1412278","article-title":"Prednisolone or Pentoxifylline for Alcoholic Hepatitis","volume":"372","author":"Thursz","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.mcna.2022.12.005_bib48","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1053\/j.gastro.2018.05.011","article-title":"Corticosteroids Reduce Risk of Death Within 28 Days for Patients With Severe Alcoholic Hepatitis, Compared With Pentoxifylline or Placebo\u2014a Meta-analysis of Individual Data From Controlled Trials","volume":"155","author":"Louvet","year":"2018","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.mcna.2022.12.005_bib49","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1053\/j.gastro.2009.04.062","article-title":"Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor","volume":"137","author":"Louvet","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mcna.2022.12.005_bib50","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMoa1105703","article-title":"Early Liver Transplantation for Severe Alcoholic Hepatitis","volume":"365","author":"Philippe","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.mcna.2022.12.005_bib51","first-page":"15","article-title":"Optimal management of alcoholic hepatitis","volume":"60","author":"Raff","year":"2014","journal-title":"Minerva Gastroenterol Dietol"},{"issue":"2","key":"10.1016\/j.mcna.2022.12.005_bib52","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4292\/wjgpt.v4.i2.16","article-title":"Management practices of hepatitis C virus infected alcoholic hepatitis patients: A survey of physicians","volume":"4","author":"Singal","year":"2013","journal-title":"World J Gastrointest Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.mcna.2022.12.005_bib53","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: A double-blind, placebo-controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.mcna.2022.12.005_bib54","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1053\/j.gastro.2015.06.006","article-title":"Comparative Effectiveness of Pharmacological Interventions for Severe Alcoholic Hepatitis: A Systematic Review and Network Meta-analysis","volume":"149","author":"Singh","year":"2015","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.mcna.2022.12.005_bib55","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/lt.24986","article-title":"Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: A multinational, prospective, controlled, randomized trial","volume":"24","author":"Thompson","year":"2018","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.mcna.2022.12.005_bib56","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jhep.2018.10.026","article-title":"Current trials and novel therapeutic targets for alcoholic hepatitis","volume":"70","author":"Singal","year":"2019","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.mcna.2022.12.005_bib57","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cld.2021.03.006","article-title":"Emerging Therapies for Alcoholic Hepatitis","volume":"25","author":"Thanda Han","year":"2021","journal-title":"Clin Liver Dis"},{"issue":"5","key":"10.1016\/j.mcna.2022.12.005_bib58","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.alcohol.2008.03.131","article-title":"Alcohol, Intestinal Bacterial Growth, Intestinal Permeability to Endotoxin, and Medical Consequences","volume":"42","author":"Purohit","year":"2008","journal-title":"Alcohol"},{"issue":"4","key":"10.1016\/j.mcna.2022.12.005_bib59","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.cgh.2016.10.029","article-title":"Healthy Donor Fecal Microbiota Transplantation in Steroid-Ineligible Severe Alcoholic Hepatitis: A Pilot Study","volume":"15","author":"Philips","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.mcna.2022.12.005_bib60","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/hep.31496","article-title":"A\u00a0Randomized Clinical Trial of Fecal Microbiota Transplant for Alcohol Use Disorder","volume":"73","author":"Bajaj","year":"2021","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.mcna.2022.12.005_bib61","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jceh.2022.01.001","article-title":"Long-term Outcomes of Stool Transplant in Alcohol-associated Hepatitis\u2014Analysis of Clinical Outcomes, Relapse, Gut Microbiota and Comparisons with Standard Care","volume":"12","author":"Philips","year":"2022","journal-title":"J\u00a0Clin Exp Hepatol"},{"issue":"4","key":"10.1016\/j.mcna.2022.12.005_bib62","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/hep.32478","article-title":"IL-1 receptor antagonist plus pentoxifylline and zinc for severe alcohol-associated hepatitis","volume":"76","author":"Szabo","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2022.12.005_bib63","unstructured":"Gawrieh S, Dasarathy S, Tu W, et\u00a0al. Anakinra plus Zinc versus Prednisone for Treatment of Severe Alcohol-Associated Hepatitis: A Randomized Controlled Trial. Poster presented at: The Liver Meeting. November 4-8, 2012; Washington D.C."},{"issue":"6","key":"10.1016\/j.mcna.2022.12.005_bib64","first-page":"1483A","article-title":"Safety and Efficacy of DUR-928: A Potential New Therapy for Acute Alcoholic Hepatitis","volume":"70","author":"Hassanein","year":"2019","journal-title":"Hepatology"},{"issue":"19","key":"10.1016\/j.mcna.2022.12.005_bib65","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1101214","article-title":"Glucocorticoids plus N -Acetylcysteine in Severe Alcoholic Hepatitis","volume":"365","author":"Nguyen-Khac","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"16","key":"10.1016\/j.mcna.2022.12.005_bib66","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.3748\/wjg.v21.i16.4975","article-title":"Metadoxine improves the three- and six-month survival rates in patients with severe alcoholic hepatitis","volume":"21","author":"Higuera-de la Tijera","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.mcna.2022.12.005_bib67","doi-asserted-by":"crossref","first-page":"G1019","DOI":"10.1152\/ajpgi.00239.2006","article-title":"IL-22-mediated liver cell regeneration is abrogated by SOCS-1\/3 overexpression in\u00a0vitro","volume":"292","author":"Brand","year":"2007","journal-title":"Am J Physiology-Gastrointestinal Liver Physiol"},{"issue":"2","key":"10.1016\/j.mcna.2022.12.005_bib68","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/hep.31046","article-title":"An open label, dose escalation study to assess the safety and efficacy of il-22 agonist f-652 in patients with alcoholic hepatitis","volume":"72","author":"Arab","year":"2020","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.mcna.2022.12.005_bib69","doi-asserted-by":"crossref","first-page":"100139","DOI":"10.1016\/j.jhepr.2020.100139","article-title":"Granulocyte colony-stimulating factor for alcoholic hepatitis: A systematic review and meta-analysis of randomised controlled trials","volume":"2","author":"Marot","year":"2020","journal-title":"JHEP Rep"},{"issue":"6","key":"10.1016\/j.mcna.2022.12.005_bib70","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/lt.500030613","article-title":"Minimal criteria for placement of adults on the liver transplant waiting list: A report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases","volume":"3","author":"Lucey","year":"1997","journal-title":"Liver Transplant Surg"},{"issue":"3","key":"10.1016\/j.mcna.2022.12.005_bib71","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/lt.500030305","article-title":"Liver transplantation for alcoholic liver disease: A survey of transplantation programs in the United States","volume":"3","author":"Everhart","year":"1997","journal-title":"Liver Transplant Surg"},{"issue":"3","key":"10.1016\/j.mcna.2022.12.005_bib72","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/lt.20086","article-title":"Analysis of factors that predict alcohol relapse following liver transplantation","volume":"10","author":"Jauhar","year":"2004","journal-title":"Liver Transplant"},{"issue":"4","key":"10.1016\/j.mcna.2022.12.005_bib74","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/alcalc\/agl033","article-title":"Liver transplantation for alcoholic liver disease: a systematic review of psychosocial selection criteria","volume":"41","author":"Mccallum","year":"2006","journal-title":"Alcohol Alcohol"},{"issue":"17","key":"10.1016\/j.mcna.2022.12.005_bib75","doi-asserted-by":"crossref","first-page":"771","DOI":"10.4254\/wjh.v9.i17.771","article-title":"Risk factors and outcomes associated with alcohol relapse after liver transplantation","volume":"9","author":"Lim","year":"2017","journal-title":"World J Hepatol"},{"issue":"2","key":"10.1016\/j.mcna.2022.12.005_bib76","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1053\/j.gastro.2018.04.009","article-title":"Outcomes of Early Liver Transplantation for Patients With Severe Alcoholic Hepatitis","volume":"155","author":"Lee","year":"2018","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.mcna.2022.12.005_bib77","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/SLA.0000000000001831","article-title":"Three-year Results of a Pilot Program in Early Liver Transplantation for Severe Alcoholic Hepatitis","volume":"265","author":"Lee","year":"2017","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.mcna.2022.12.005_bib78","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1053\/j.gastro.2021.08.004","article-title":"Results of Early Transplantation for Alcohol-Related Cirrhosis: Integrated Addiction Treatment With Low Rate of Relapse","volume":"161","author":"Carrique","year":"2021","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.mcna.2022.12.005_bib79","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1001\/jamasurg.2021.3748","article-title":"Evaluation of Early vs Standard Liver Transplant for Alcohol-Associated Liver Disease","volume":"156","author":"Herrick-Reynolds","year":"2021","journal-title":"JAMA Surg"},{"issue":"1","key":"10.1016\/j.mcna.2022.12.005_bib80","doi-asserted-by":"crossref","first-page":"e0190823","DOI":"10.1371\/journal.pone.0190823","article-title":"Liver transplantation for alcoholic hepatitis: A systematic review with meta-analysis","volume":"13","author":"Marot","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.mcna.2022.12.005_bib81","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/alcalc\/agx105","article-title":"Transplantation for Alcohol-related Liver Disease: Is It Fair?","volume":"53","author":"Mellinger","year":"2018","journal-title":"Alcohol Alcohol"},{"issue":"1","key":"10.1016\/j.mcna.2022.12.005_bib82","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1017\/S0963180108090051","article-title":"Responsibility and Priority in Liver Transplantation","volume":"18","author":"Glannon","year":"2009","journal-title":"Camb Q Healthc Ethics"},{"issue":"10","key":"10.1016\/j.mcna.2022.12.005_bib83","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/lt.25285","article-title":"Survey of Liver Transplantation Practices for Severe Acute Alcoholic Hepatitis: Survey of Liver Transplantation","volume":"24","author":"Bangaru","year":"2018","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.mcna.2022.12.005_bib84","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/ajt.16143","article-title":"Liver transplantation for alcoholic hepatitis in the United States: Excellent outcomes with profound temporal and geographic variation in frequency","volume":"21","author":"Cotter","year":"2021","journal-title":"Am J Transpl"},{"issue":"7","key":"10.1016\/j.mcna.2022.12.005_bib85","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1097\/TP.0000000000004049","article-title":"Rising Trend in Waitlisting for Alcoholic Hepatitis With More Favorable Outcomes Than Other High Model for End-stage Liver Disease in the Current Era","volume":"106","author":"Bittermann","year":"2022","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.mcna.2022.12.005_bib86","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/hep.29338","article-title":"Alcohol abstinence in patients surviving an episode of alcoholic hepatitis: Prediction and impact on long-term survival: Altamirano, L\u00f3pez-Pelayo, et\u00a0al","volume":"66","author":"Altamirano","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2022.12.005_bib87","article-title":"Simultaneous management of alcohol use disorder and of liver disease: a systematic review and meta-analysis","author":"Elfeki","year":"2022","journal-title":"J\u00a0Addict Med"},{"issue":"3","key":"10.1016\/j.mcna.2022.12.005_bib88","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/SLA.0000000000004211","article-title":"Predictors of Survival After Liver Transplantation in Patients With the Highest Acuity (MELD \u226540)","volume":"272","author":"Evans","year":"2020","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.mcna.2022.12.005_bib89","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/hep.29240","article-title":"Main drivers of outcome differ between short term and long term in severe alcoholic hepatitis: A prospective study","volume":"66","author":"Louvet A","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2022.12.005_bib90","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1002\/hep4.2080","article-title":"Naltrexone for alcohol use disorder: Hepatic safety in patients with and without liver disease","volume":"6","author":"Ayyala D","year":"2022","journal-title":"Hepaol Commun"},{"issue":"4","key":"10.1016\/j.mcna.2022.12.005_bib91","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/alcalc\/agu028","article-title":"Utilization of Baclofen in Maintenance of Alcohol Abstinence in Patients with Alcohol Dependence and Alcoholic Hepatitis with or without Cirrhosis","volume":"49","author":"Yamini","year":"2014","journal-title":"Alcohol Alcohol"},{"issue":"1","key":"10.1016\/j.mcna.2022.12.005_bib92","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1176\/appi.ajp.2017.1750101","article-title":"The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder","volume":"175","author":"Reus","year":"2018","journal-title":"Am J Psychiatry"},{"issue":"6","key":"10.1016\/j.mcna.2022.12.005_bib93","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1002\/hep.31042","article-title":"Impact of Alcohol Use Disorder Treatment on Clinical Outcomes among Patients with Cirrhosis","volume":"71","author":"Rogal","year":"2020","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.mcna.2022.12.005_bib94","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S2468-1253(21)00191-6","article-title":"Barriers to the management of alcohol use disorder and alcohol-associated liver disease: strategies to implement integrated care models","volume":"7","author":"DiMartini","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.mcna.2022.12.005_bib95","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/hep.31235","article-title":"Integrated Treatment of Alcohol Use Disorder in Patients With Alcohol-Associated Liver Disease: An Evolving Story","volume":"71","author":"Lucey","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2022.12.005_bib96","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jsat.2018.05.003","article-title":"Misconceptions, preferences and barriers to alcohol use disorder treatment in alcohol-related cirrhosis","volume":"91","author":"Mellinger","year":"2018","journal-title":"J\u00a0Substance Abuse Treat"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712522001754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712522001754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T10:03:47Z","timestamp":1683281027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712522001754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":95,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0025712522001754"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2022.12.005","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alcoholic Hepatitis","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2022.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}